Association of PON1 Gene Polymorphisms and Enzymatic Activity With Risk of Coronary Artery Disease

References

• Gupta N , SinghS, MaturuVN, SharmaYP, GillKD. Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis. PLoS One, 6, e17805 (2011).
   PubMed Web of Science ®Google Scholar
• Mackness B , DaviesGK, TurkieWet al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol., 21, 1451–1457 (2001).
   PubMed Web of Science ®Google Scholar
• Lakshmy R , AhmadD, AbrahamRAet al. Paraoxonase gene Q192R& L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low-density lipoprotein. Indian J. Med. Res., 131, 522–529 (2010).
   PubMed Web of Science ®Google Scholar
• Mendonça MI , DosReis RP, FreitasAIet al. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk. Rev. Port. Cardiol., 29, 571–580 (2010).
   PubMedGoogle Scholar
• Mendonça MI , DosReis RP, FreitasAIet al. Human paraoxonase gene polymorphisms and coronary artery disease risk. Rev. Port. Cardiol., 27, 1539–1555 (2008).
   PubMedGoogle Scholar
• Gupta N , BinuKB, SinghSet al. Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics. Gene, 498, 13–19 (2012).
   PubMed Web of Science ®Google Scholar
• van Himbergen TM , vander Schouw YT, VoorbijHAet al. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis, 199, 408–414 (2008).
   PubMed Web of Science ®Google Scholar
• Schmidt H , SchmidtR, NiederkornKet al. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke, 29, 2043–8 (1998)
   PubMed Web of Science ®Google Scholar
• Mackness B , DurringtonP, McElduffPet al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation, 107, 2775–2779 (2003).
   PubMed Web of Science ®Google Scholar
• Ombres D , PannitteriG, MoutaliAet al. The Gln-Arg 192 polymorphism of the human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler. Thromb. Vasc. Biol., 18, 1611–1616 (1998).
   PubMed Web of Science ®Google Scholar
• Antikainen M , MurtomäkiS, SyvänneMet al. The Gln-Arg 191 polymorphism of human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J. Clin. Invest., 98, 883–885 (1996).
   PubMed Web of Science ®Google Scholar
• Wheeler JG , KeavneyBD, WatkinsH, CollinsR, DaneshJ. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet, 363, 689–695 (2004).
   PubMed Web of Science ®Google Scholar
• Hernández-Díaz Y , Tovilla-ZárateCA, Juárez-RojopIEet al. Effects of paraoxonase 1 gene polymorphisms on heart diseases: systematic review and meta-analysis of 64 case–control studies. Medicine (Baltimore), 95, e5298 (2016).
   PubMed Web of Science ®Google Scholar
• Mackness B , MacknessMI, ArrolS, TurkieW, DurringtonPN. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br. J. Pharmacol., 122, 265–268 (1997).
   PubMed Web of Science ®Google Scholar
• Pati N , PatiU. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects. Int. J. Cardiol., 66, 165–168 (1998).
   PubMed Web of Science ®Google Scholar
• Agrawal S , TripathiG, PrajnyaRet al. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians. Indian J. Med. Sci., 63, 335–344 (2009).
   PubMedGoogle Scholar
• Munshi R , PanchalP, ChaurasiaA, RajadhyakshaG. Association between Paraoxonase 1 (PON1) gene polymorphisms and PON1 enzyme activity in indian patients with coronary artery disease (CAD). Curr. Pharmacogenomics Person. Med., 16, 219–229 (2018).
   Google Scholar
• Mastana SS . Unity in diversity: an overview of the genomic anthropology of India. Ann. Hum. Biol., 41, 287–299 (2014).
   PubMed Web of Science ®Google Scholar
• Souich DP , OrmeM, ErillSet al. The IUPHAR compendium of basic principles for pharmacological research in humans(2018). http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.463.6567&rep=rep1&type=pdf
   Google Scholar
• Sambrook J , FritsctEF, ManiatisT. Molecular cloning: A laboratory manual (2nd Edition). Cold Spring Harbour Laboratory, NY, USA (1989).
   Google Scholar
• Sanghera DK , SahaN, AstonCE, KambohMI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol., 17, 1067–1073 (1997).
   PubMed Web of Science ®Google Scholar
• Zama T , MurataM, MatsubaraYet al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler. Thromb. Vasc. Biol., 17, 3565–3569 (1997).
   PubMed Web of Science ®Google Scholar
• Schiavon R , DeFanti E, GiavarinaD, BiasioliS, CavalcantiG, GuidiG. Serum paraoxonase activity is decreased in uremic patients. Clin. Chim. Acta, 29, 71–80 (1996).
   Google Scholar
• Kedage V , MuttigiMS, ShettyMSet al. Serum paraoxonase 1 activity status in patients with liver disorders. Saudi J. Gastroenterol., 16, 79–83 (2010).
   PubMedGoogle Scholar
• Jarvik GP , HatsukamiTS, CarlsonCet al. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler. Thromb. Vasc. Biol., 23, 1465–1471 (2003).
   PubMed Web of Science ®Google Scholar
• Krishnan MN . Coronary heart disease and risk factors in India – On the brink of an epidemic?Indian Heart J., 64, 364–367 (2012).
   PubMedGoogle Scholar
• Genetics power calculator. http://zzz.bwh.harvard.edu/gpc/cc2.html
   Google Scholar
• Sanghera DK , AstonCE, SahaN, KambohMI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am. J. Hum. Genet., 62, 36–44 (1998).
   PubMed Web of Science ®Google Scholar
• Zhao Y , MaY, FangYet al. Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies. Mol. Genet. Metab., 105, 141–148 (2012).
   PubMed Web of Science ®Google Scholar
• Cheraghi M , ShahsavariG, MalekiA, AhmadvandH. Paraoxonase 1 activity, lipid profile, and atherogenic indexes status in coronary heart disease. Rep. Biochem. Mol. Biol., 6(1), 1–7 (2017).
   PubMed Web of Science ®Google Scholar
• Januszek R . Paraoxonase-1 and simvastatin treatment in patients with stable coronary artery disease. Int. J. Vasc. Med., 2016, 6312478 (2016).
   PubMedGoogle Scholar
• Aviram M , HardakE, VayaJet al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation, 101, 2510–2517 (2000).
   PubMed Web of Science ®Google Scholar
• James RW , LevievI, RighettiA. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation, 101, 2252–2257 (2000).
   PubMed Web of Science ®Google Scholar
• van der Gaag MS , van TolA, ScheekLMet al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle aged men. Atherosclerosis, 147, 405–410 (1999).
   PubMed Web of Science ®Google Scholar